Vericel Corp Files Q1 2025 10-Q
Ticker: VCEL · Form: 10-Q · Filed: May 8, 2025 · CIK: 887359
Sentiment: neutral
Topics: 10-Q, financials, sec-filing
Related Tickers: VCEL
TL;DR
VCEL Q1 2025 10-Q filed. Financials and biz details out.
AI Summary
Vericel Corp filed its 10-Q for the period ending March 31, 2025. The company, headquartered in Cambridge, MA, operates in the biological products sector. Key financial data and business addresses are included in the filing, which was submitted on May 8, 2025.
Why It Matters
This filing provides investors with the latest financial performance and operational details for Vericel Corp, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing (10-Q) and does not inherently present new risks beyond those typically associated with public companies.
Key Numbers
- 20250331 — Period End Date (The end of the reporting quarter)
- 20250508 — Filing Date (Date the 10-Q was submitted to the SEC)
Key Players & Entities
- Vericel Corp (company) — Filer of the 10-Q
- 0001628280-25-023496 (other) — Accession Number for the filing
- 20250331 (date) — Conformed period of report
- 20250508 (date) — Filing date
- Cambridge, MA (location) — Company headquarters and business address
- 64 Sidney St. (address) — Company business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 8, 2025.
What is Vericel Corp's primary business sector?
Vericel Corp is in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, SIC code 2836.
Where is Vericel Corp located?
Vericel Corp's business and mailing address is 64 Sidney St., Cambridge, MA 02139.
What was the previous company name and when did the name change occur?
The former company name was AASTROM BIOSCIENCES INC, and the date of name change was April 28, 1996.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Vericel Corp (VCEL).